Flynn, Aidan <br/><br/>
Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease.  [electronic resource] 

 -  IDrugs : the investigational drugs journal  Apr 2008 
 - 283-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1369-7056 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Coronary Artery Disease--genetics<br/>Drug Evaluation, Preclinical<br/>Fibroblast Growth Factor 4--adverse effects<br/>Genetic Therapy<br/>Genetic Vectors<br/>Humans<br/>Neovascularization, Physiologic--genetics<br/>Patents as Topic<br/>Structure-Activity Relationship